LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Technology Breakthrough in Deep Light Imaging to Improve Disease Diagnosis

By LabMedica International staff writers
Posted on 13 Jul 2023
Print article
Image: New deep light imaging could improve disease diagnosis (Photo courtesy of Freepik)
Image: New deep light imaging could improve disease diagnosis (Photo courtesy of Freepik)

Optical coherence tomography (OCT), an important form of light imaging, operates on the principle of light backscattering within the sample under observation, similar to how light gets scattered in fog due to water droplets possessing different refractive indices than the air. Just as the scattering makes it hard to see through fog, the scattering by cellular components and smaller constituents in biological tissue also complicates imaging tasks. Specifically, acquiring a clear signal from depths surpassing 1mm presents significant difficulties, chiefly because of intervening tissue. Now, a technological breakthrough in OCT is set to revolutionize applications in fields like ophthalmology, dermatology, cardiology, and early cancer detection, as well as improve disease diagnosis.

Traditional understanding holds that the OCT signal is largely influenced by light that has experienced a single backscattering event, while light that has been scattered numerous times hampers image creation. An international team of researchers, in collaboration with the University of St Andrews (Scotland, UK), have uncovered a contrasting perspective. They suggest that selectively gathering multiply scattered light could enhance image contrast at depth, especially in highly scattering samples. The researchers further demonstrated how this technique could be applied in a simple way with minimal additional optics, by shifting the light delivery and collection pathways. The team is confident that their ground-breaking discovery has the potential to challenge existing conventions and bring about a significant shift in retrieving images at depth.

“The unique configuration, supported by our modeling, should redefine our view on OCT signal formation – and we can now use this insight to extract more information and to improve diagnosis of disease,” said Dr. Peter Andersen, co-corresponding author from Technical University of Denmark.

Related Links:
University of St Andrews 

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.